Inserm Transfert Initiative is a seed stage life science vehicle currently managing about €4.2M for the financing of new biotech
Inserm Transfert Initiative is a seed stage life science vehicle currently managing about €4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 19, 2020
VectivBio
|
Series Unknown | $110M | Biotechnology | — |
Jan 8, 2020
VectivBio
|
Series A | $35M | Biotechnology | — |
Jan 8, 2020
Eyevensys
|
Series B | $30M | Biotechnology | — |
Dec 13, 2019
Aelis Farma
|
Series Unknown | €11M | Biotechnology | — |
Aug 9, 2018
Therachon
|
Series B | $60M | Biotechnology | — |
Inserm Transfert Initiative has had 5 exits. Inserm Transfert Initiative most notable exits include Aelis Farma , VectivBio
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Feb 16, 2022 | Aelis Farma | IPO | Biotechnology | Detail |
Apr 8, 2021 | VectivBio | IPO | Biotechnology | Detail |
May 8, 2019 | Therachon | M&A | Biotechnology | Detail |
Apr 30, 2015 | Sensorion | IPO | Biopharma | Detail |
Jan 1, 2006 | Pharma Omnium | M&A | Health Care | Detail |